Patent · US Active

Arginase inhibitors and methods of use thereof

US11912727B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Scott Nathan MLYNARSKI · Waltham, US
Tyler GREBE · Waltham, US
Sameer KAWATKAR · Waltham, US
Maurice Raymond Verschoyle Finlay · Cambridge, GB
Iain Simpson · Cambridge, GB
Jianyan Wang · Waltham, US
Steve Cook · Waltham, US
Dedong Wu · Newton, US

Key dates

Filing date	Jul 10, 2023
Grant date	Feb 27, 2024
Priority date	—
Expiry date	Jul 10, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds of formula (Ia) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of formula (Ia) and methods of using the same for treating cancer or a respiratory inflammatory disease and inhibiting arginase: wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.